NONINVASIVE AND CURATIVE RADIATION THERAPY FOR SEBACEOUS CARCINOMA OF THE EYELID

被引:34
作者
Hata, Masaharu [1 ]
Koike, Izumi
Omura, Motoko
Maegawa, Jiro [2 ]
Ogino, Ichiro [3 ]
Inoue, Tomio
机构
[1] Yokohama City Univ, Grad Sch Med, Dept Radiol, Kanazawa Ku, Yokohama, Kanagawa 2360004, Japan
[2] Yokohama City Univ, Grad Sch Med, Dept Plast & Reconstruct Surg, Yokohama, Kanagawa 2360004, Japan
[3] Yokohama City Univ, Med Ctr, Dept Radiat Oncol, Yokohama, Kanagawa 2360004, Japan
来源
INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS | 2012年 / 82卷 / 02期
关键词
Eyelid; Organ preservation; Radiation therapy; Sebaceous carcinoma; MEIBOMIAN GLAND CARCINOMA; ORBITAL LYMPHOMA; PAGETOID SPREAD; CELL-CARCINOMA; ONCOLOGY-GROUP; OCULAR ADNEXA; MITOMYCIN-C; MANAGEMENT; RADIOTHERAPY; ADENOCARCINOMA;
D O I
10.1016/j.ijrobp.2010.12.006
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Purpose: Sebaceous carcinoma of the eyelid is a rare malignancy. Surgical excision remains the standard and most reliable curative treatment. However, surgery is sometimes not possible because many patients are elderly, and it frequently causes functional and cosmetic impairment of the eyelid. We therefore carried out a study to determine: the role of radiation therapy in relation to sebaceous carcinoma of the eyelid. Methods and Materials: Thirteen patients with sebaceous carcinoma of the eyelid underwent radiation therapy with curative intent. There were 6 men and 7 women, and their ages at irradiation ranged from 60 to 85 years (me.. dian, 78 years). Only 1 patient had cervical lymph node metastasis, and none of the patients had distant metastasis. A total dose of 50 to 66.6 Gy (median, 60 Gy) was delivered to tumor sites in 22 to 37 fractions. Results: All irradiated tumors were controlled at a median follow-up period of 55 months. Only 1 patient had re.. currence of cervical lymph node metastasis outside the radiation field, at 22 months after irradiation. The 5-year local progression free and disease-free rates were 100% and 89%, respectively. The overall and disease-free sur. vival rates at 5 years were 100% and 89%, respectively. Although acute and transient therapy-related reactions of Grade 2 or less were observed, there were no severe toxicities of Grade 3 or greater. Conclusions: Radiation therapy is a safe and effective treatment for patients with sebaceous carcinoma of the eye.. lid. It appears to contribute to prolonged survival as a result of good tumor control, and it also facilitates functional and cosmetic preservation of the eyelid. (C) 2012 Elsevier Inc.
引用
收藏
页码:605 / 611
页数:7
相关论文
共 50 条
  • [1] Radiation therapy for primary carcinoma of the eyelid: tumor control and visual function
    Hata, M.
    Koike, I.
    Maegawa, J.
    Kaneko, A.
    Odagiri, K.
    Kasuya, T.
    Minagawa, Y.
    Kaizu, H.
    Mukai, Y.
    Inoue, T.
    STRAHLENTHERAPIE UND ONKOLOGIE, 2012, 188 (12) : 1102 - 1107
  • [2] Radiotherapy for localized sebaceous carcinoma of the eyelid: a retrospective analysis of 83 patients
    Takagawa, Yoshiaki
    Tamaki, Wakana
    Suzuki, Shigenobu
    Inaba, Koji
    Murakami, Naoya
    Takahashi, Kana
    Igaki, Hiroshi
    Nakayama, Yuko
    Shigematsu, Naoyuki
    Itami, Jun
    JOURNAL OF RADIATION RESEARCH, 2019, 60 (05) : 622 - 629
  • [3] Sebaceous Carcinoma of the Eyelid: A Systematic Review and Meta-Analysis
    Desiato, Vincent M.
    Byun, Young Jae
    Nguyen, Shaun A.
    Thiers, Bruce H.
    Day, Terry A.
    DERMATOLOGIC SURGERY, 2021, 47 (01) : 104 - 110
  • [4] Molecular landscape of eyelid sebaceous gland carcinoma: A comprehensive review
    Jayaraj, Perumal
    Ray, Debjeet
    Goel, Kevika
    Singh, Ananya
    Kant, Nimita
    Sen, Seema
    INDIAN JOURNAL OF OPHTHALMOLOGY, 2024, 72 (10) : 1393 - 1403
  • [5] Sebaceous gland carcinoma of the eyelid: clinicopathological features and outcome in Asian Indians
    Kaliki, S.
    Ayyar, A.
    Dave, T. V.
    Ali, M. J.
    Mishra, D. K.
    Naik, M. N.
    EYE, 2015, 29 (07) : 958 - 963
  • [6] Nordic treatment practices survey and consensus for treatment of eyelid sebaceous carcinoma
    Leivo, Tiina
    Sarmela, Johanna
    Enckell-Aaltonen, Maria
    Kopp, Eva Dafgard
    Schmitt, Caroline
    Toft, Peter B.
    Sigurdsson, Haraldur
    Uusitalo, Marita
    BMC OPHTHALMOLOGY, 2020, 20 (01)
  • [7] Sebaceous Carcinoma of the Eyelid
    Prieto-Granada, Carlos
    Rodriguez-Waitkus, Paul
    CANCER CONTROL, 2016, 23 (02) : 126 - 132
  • [8] Sebaceous carcinoma of the eyelid: anatomoclinical data
    Costea, Claudia Florida
    Petraru, D.
    Dumitrescu, Gabriela
    Sava, Anca
    ROMANIAN JOURNAL OF MORPHOLOGY AND EMBRYOLOGY, 2013, 54 (03) : 665 - 668
  • [9] SEBACEOUS CARCINOMA OF THE EYELID AND MUIRTORRE SYNDROME
    Randelovic, Karla
    Ivekovic, Renata
    Zrinscak, Ognjen
    Cupic, Hrvoje
    Ramic, Snjezana
    Vatavuk, Zoran
    Vickovic, Ivanka Petric
    ACTA CLINICA CROATICA, 2023, 62 (04) : 731 - 734
  • [10] Promising Results of an Exclusive Radiotherapy Treatment of an Inoperable Giant Eyelid Sebaceous Carcinoma
    Hamdan, Asmae
    El Baz, Salma
    El Kacemi, Hanan
    Kebdani, Tayeb
    Hassouni, Khalid
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2024, 16 (06)